Interactions Between the Intestinal Microbiome and Liver Diseases

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466 Williams, 2011, Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study, Gastroenterology, 140, 124, 10.1053/j.gastro.2010.09.038 Caldwell, 2010, The natural history of non-alcoholic fatty liver disease, Dig Dis, 28, 162, 10.1159/000282081 Wu, 2011, Linking long-term dietary patterns with gut microbial enterotypes, Science, 334, 105, 10.1126/science.1208344 Raman, 2013, Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 11, 868, 10.1016/j.cgh.2013.02.015 Mouzaki, 2013, Intestinal microbiota in patients with nonalcoholic fatty liver disease, Hepatology, 58, 120, 10.1002/hep.26319 Zhu, 2013, Characterization of the gut microbiome in non-alcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH, Hepatology, 57, 601, 10.1002/hep.26093 Miele, 2009, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, Hepatology, 49, 1877, 10.1002/hep.22848 Sabate, 2008, High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis, Obes Surg, 18, 371, 10.1007/s11695-007-9398-2 Wigg, 2001, The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis, Gut, 48, 206, 10.1136/gut.48.2.206 Bode, 2005, Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?, Alcohol Clin Exp Res, 29, 166S, 10.1097/01.alc.0000189280.19073.28 Yan, 2012, Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease, World J Hepatol, 4, 110, 10.4254/wjh.v4.i4.110 Mutlu, 2012, Colonic microbiome is altered in alcoholism, Am J Physiol Gastrointest Liver Physiol, 302, G966, 10.1152/ajpgi.00380.2011 Schnabl, 2013, Linking intestinal homeostasis and liver disease, Curr Opin Gastroenterol, 29, 264, 10.1097/MOG.0b013e32835ff948 Yan, 2011, Enteric dysbiosis associated with a mouse model of alcoholic liver disease, Hepatology, 53, 96, 10.1002/hep.24018 Hartmann, 2013, Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice, Hepatology, 58, 108, 10.1002/hep.26321 Nanji, 1994, Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease), Proc Soc Exp Biol Med, 205, 243, 10.3181/00379727-205-43703 Forsyth, 2009, Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis, Alcohol, 43, 163, 10.1016/j.alcohol.2008.12.009 Wang, 2012, Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury, Am J Physiol Gastrointest Liver Physiol, 303, G32, 10.1152/ajpgi.00024.2012 Kirpich, 2008, Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study, Alcohol, 42, 675, 10.1016/j.alcohol.2008.08.006 Bode, 1984, Jejunal microflora in patients with chronic alcohol abuse, Hepatogastroenterology, 31, 30 Wegener, 1991, Gastrointestinal transit of solid-liquid meal in chronic alcoholics, Dig Dis Sci, 36, 917, 10.1007/BF01297141 Bode, 1997, Alcohol's role in gastrointestinal tract disorders, Alcohol Health Res World, 21, 76 Salaspuro, 1999, Ethanol oxidation and acetaldehyde production in vitro by human intestinal strains of Escherichia coli under aerobic, microaerobic, and anaerobic conditions, Scand J Gastroenterol, 34, 967, 10.1080/003655299750025057 Poynard, 2000, Natural history of HCV infection, Baillieres Best Pract Res Clin Gastroenterol, 14, 211, 10.1053/bega.1999.0071 Gines, 2004, Management of cirrhosis and ascites, N Engl J Med, 350, 1646, 10.1056/NEJMra035021 Lu, 2011, Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients, Microb Ecol, 61, 693, 10.1007/s00248-010-9801-8 Chen, 2011, Characterization of fecal microbial communities in patients with liver cirrhosis, Hepatology, 54, 562, 10.1002/hep.24423 Xu, 2012, Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease, Microb Ecol, 63, 304, 10.1007/s00248-011-9925-5 Wu, 2012, Assessment of the fecal Lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant, Microb Ecol, 63, 929, 10.1007/s00248-011-9945-1 Bajaj, 2012, Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation, Am J Physiol Gastrointest Liver Physiol, 303, G675, 10.1152/ajpgi.00152.2012 Bajaj, 2012, Linkage of gut microbiome with cognition in hepatic encephalopathy, Am J Physiol Gastrointest Liver Physiol, 302, G168, 10.1152/ajpgi.00190.2011 Bauer, 2002, Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia, Am J Gastroenterol, 97, 2364, 10.1111/j.1572-0241.2002.05791.x Bauer, 2001, Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis, Am J Gastroenterol, 96, 2962, 10.1111/j.1572-0241.2001.04668.x Chang, 1998, Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis, Hepatology, 28, 1187, 10.1002/hep.510280504 Teltschik, 2012, Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense, Hepatology, 55, 1154, 10.1002/hep.24789 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Ley, 2005, Obesity alters gut microbial ecology, Proc Natl Acad Sci U S A, 102, 11070, 10.1073/pnas.0504978102 Backhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc Natl Acad Sci U S A, 101, 15718, 10.1073/pnas.0407076101 Backhed, 2007, Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc Natl Acad Sci U S A, 104, 979, 10.1073/pnas.0605374104 Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540 Cope, 2000, Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis, Gastroenterology, 119, 1340, 10.1053/gast.2000.19267 Hartmann, 2012, The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease, Front Physiol, 3, 402, 10.3389/fphys.2012.00402 Blumberg, 1941, The prevention by choline of liver cirrhosis in rats on high fat, low protein diets, Science, 93, 598, 10.1126/science.93.2425.598 Dumas, 2006, Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice, Proc Natl Acad Sci U S A, 103, 12511, 10.1073/pnas.0601056103 Jiang, 2005, Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants, J Biol Chem, 280, 18336, 10.1074/jbc.M500007200 Wang, 2011, Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922 Tang, 2013, Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk, N Engl J Med, 368, 1575, 10.1056/NEJMoa1109400 Spencer, 2011, Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency, Gastroenterology, 140, 976, 10.1053/j.gastro.2010.11.049 Alisi, 2010, Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children, J Pediatr Gastroenterol Nutr, 50, 645, 10.1097/MPG.0b013e3181c7bdf1 Farhadi, 2008, Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis, Liver Int, 28, 1026, 10.1111/j.1478-3231.2008.01723.x Saberi, 2009, Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice, Cell Metab, 10, 419, 10.1016/j.cmet.2009.09.006 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Rivera, 2007, Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis, J Hepatol, 47, 571, 10.1016/j.jhep.2007.04.019 Yang, 1997, Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis, Proc Natl Acad Sci U S A, 94, 2557, 10.1073/pnas.94.6.2557 Pendyala, 2011, Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis, Am J Clin Nutr, 93, 234, 10.3945/ajcn.110.002683 Ding, 2010, High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse, PLoS One, 5, e12191, 10.1371/journal.pone.0012191 Henao-Mejia, 2012, Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, Nature, 482, 179, 10.1038/nature10809 Parlesak, 2000, Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease, J Hepatol, 32, 742, 10.1016/S0168-8278(00)80242-1 Adachi, 1995, Antibiotics prevent liver injury in rats following long-term exposure to ethanol, Gastroenterology, 108, 218, 10.1016/0016-5085(95)90027-6 Ferrier, 2006, Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents, Am J Pathol, 168, 1148, 10.2353/ajpath.2006.050617 Uesugi, 2001, Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice, Hepatology, 34, 101, 10.1053/jhep.2001.25350 Elamin, 2013, Ethanol metabolism and its effects on the intestinal epithelial barrier, Nutr Rev, 71, 483, 10.1111/nure.12027 Rao, 2004, Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease, Am J Physiol Gastrointest Liver Physiol, 286, G881, 10.1152/ajpgi.00006.2004 Wang, 2011, Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury, Am J Pathol, 179, 2866, 10.1016/j.ajpath.2011.08.039 Turner, 2009, Intestinal mucosal barrier function in health and disease, Nat Rev Immunol, 9, 799, 10.1038/nri2653 Tranah, 2013, Systemic inflammation and ammonia in hepatic encephalopathy, Metab Brain Dis, 28, 1, 10.1007/s11011-012-9370-2 Sidhu, 2011, Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial), Am J Gastroenterol, 106, 307, 10.1038/ajg.2010.455 Bass, 2010, Rifaximin treatment in hepatic encephalopathy, N Engl J Med, 362, 1071, 10.1056/NEJMoa0907893 Bellot, 2013, Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications, Liver Int, 33, 31, 10.1111/liv.12021 Arvaniti, 2010, Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis, Gastroenterology, 139, 10.1053/j.gastro.2010.06.019 Wiest, 2014, Pathological bacterial translocation in liver cirrhosis, J Hepatol, 60, 197, 10.1016/j.jhep.2013.07.044 Kalambokis, 2012, Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis, Hepatology, 55, 655, 10.1002/hep.24751 Du Plessis, 2013, Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function, J Hepatol, 58, 1125, 10.1016/j.jhep.2013.01.038 Munoz, 2012, Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis, Hepatology, 56, 1861, 10.1002/hep.25854 Swann, 2011, Systemic gut microbial modulation of bile acid metabolism in host tissue compartments, Proc Natl Acad Sci U S A, 108, 4523, 10.1073/pnas.1006734107 Kakiyama, 2013, Modulation of the fecal bile acid profile by gut microbiota in cirrhosis, J Hepatol, 58, 949, 10.1016/j.jhep.2013.01.003 Xie, 2013, Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption, FASEB J, 27, 3583, 10.1096/fj.13-231860 Tanaka, 2012, Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis, Hepatology, 56, 118, 10.1002/hep.25630 Lorenzo-Zuniga, 2003, Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats, Hepatology, 37, 551, 10.1053/jhep.2003.50116 Inagaki, 2006, Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor, Proc Natl Acad Sci U S A, 103, 3920, 10.1073/pnas.0509592103 Prawitt, 2011, Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity, Diabetes, 60, 1861, 10.2337/db11-0030 Mudaliar, 2013, Efficacy and safety of the farnesoid x receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease, Gastroenterology, 145, 574, 10.1053/j.gastro.2013.05.042 Fickert, 2009, Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts, Am J Pathol, 175, 2392, 10.2353/ajpath.2009.090114 Watanabe, 2006, Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation, Nature, 439, 484, 10.1038/nature04330 Thomas, 2009, TGR5-mediated bile acid sensing controls glucose homeostasis, Cell Metab, 10, 167, 10.1016/j.cmet.2009.08.001